Loading…
Inverse Association between the Existence of CRISPR/Cas Systems with Antibiotic Resistance, Extended Spectrum β-Lactamase and Carbapenemase Production in Multidrug, Extensive Drug and Pandrug-Resistant Klebsiella pneumoniae
Antimicrobial resistance, with the production of extended-spectrum β-lactamases (ESBL) and carbapenemases, is common in the opportunistic pathogen, . This organism has a genome that can contain clustered regularly interspaced short palindromic repeats (CRISPRs), which operate as a defense mechanism...
Saved in:
Published in: | Antibiotics (Basel) 2023-05, Vol.12 (6), p.980 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c500t-d07803ae2853bbfc2942e7de01714c1f3885e0b664ddcd510b3603a660f475a03 |
---|---|
cites | cdi_FETCH-LOGICAL-c500t-d07803ae2853bbfc2942e7de01714c1f3885e0b664ddcd510b3603a660f475a03 |
container_end_page | |
container_issue | 6 |
container_start_page | 980 |
container_title | Antibiotics (Basel) |
container_volume | 12 |
creator | Jwair, Noor A Al-Ouqaili, Mushtak T S Al-Marzooq, Farah |
description | Antimicrobial resistance, with the production of extended-spectrum β-lactamases (ESBL) and carbapenemases, is common in the opportunistic pathogen,
. This organism has a genome that can contain clustered regularly interspaced short palindromic repeats (CRISPRs), which operate as a defense mechanism against external invaders such as plasmids and viruses. This study aims to determine the association of the CRISPR/Cas systems with antibiotic resistance in
isolates from Iraqi patients. A total of 100
isolates were collected and characterized according to their susceptibility to different antimicrobial agents. The CRISPR/Cas systems were detected via PCR. The phenotypic detection of ESBLs and carbapenemases was performed. The production of ESBL was detected in 71% of the isolates. Carbapenem-resistance was detected in 15% of the isolates, while only 14% were susceptible to all antimicrobial agents. Furthermore, the bacteria were classified into multidrug (77%), extensively drug-resistant (11.0%) and pandrug-resistant (4.0%). There was an inverse association between the presence of the CRISPR/Cas systems and antibiotic resistance, as resistance was higher in the absence of the CRISPR/Cas system. Multidrug resistance in ESBL-producing and carbapenem-resistant
occurred more frequently in strains negative for the CRISPR/Cas system. Thus, we conclude that genes for exogenous antibiotic resistance can be acquired in the absence of the CRISPR/Cas modules that can protect the bacteria against acquiring foreign DNA. |
doi_str_mv | 10.3390/antibiotics12060980 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_01ea51eb4fda453a9b556b115a8fb730</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_01ea51eb4fda453a9b556b115a8fb730</doaj_id><sourcerecordid>2829697877</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-d07803ae2853bbfc2942e7de01714c1f3885e0b664ddcd510b3603a660f475a03</originalsourceid><addsrcrecordid>eNptUttuEzEQXSEQrUq_AAlZ4oUHltrrvfkJRaFARBBRAs8rX2YTR7t2antT-lt8CN_Ap-BcGrUIP9gz43POjMeTJC8Jfkcpw1fcBC20DVp6kuESsxo_Sc4zXLG0pHX29IF9llx6v8ZxMUJrXD9PzmhFK5wxdp78mZgtOA9o5L2VmgdtDRIQbgEMCitA1z-1D2AkINui8XyymM2vxtyjxV0M9x7d6rBCo1M1aA4-EngkvI3cyFSg0GIDMrihR79_pVMuA-95TMmNQmPuBN-AgX1k5qwa5L4GbdDXoQtauWF5VPJ6C-hD9PfMWdyind4nDOhLB8Jr6DqONgaG3hrN4UXyrOWdh8vjeZH8-Hj9ffw5nX77NBmPpqksMA6pwlWNKYesLqgQrcxYnkGlAJOK5JK0tK4LwKIsc6WkKggWtIz4ssRtXhUc04tkctBVlq-bjdM9d3eN5brZB6xbNtzFBnXQYAK8ICDyVvG8oJyJoigFIQWvW1HRndb7g9ZmED0oCSY43j0SfXxj9KpZ2m1D4qcWGSFR4c1RwdmbAXxoeu3lrjUG7OCbrKa4LBmrWIS-_ge6toMzsVcRlbGSVXVVRRQ9oKSz3jtoT9UQ3OwmsvnPREbWq4cPOXHu54_-BXwE5VI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2829697877</pqid></control><display><type>article</type><title>Inverse Association between the Existence of CRISPR/Cas Systems with Antibiotic Resistance, Extended Spectrum β-Lactamase and Carbapenemase Production in Multidrug, Extensive Drug and Pandrug-Resistant Klebsiella pneumoniae</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Jwair, Noor A ; Al-Ouqaili, Mushtak T S ; Al-Marzooq, Farah</creator><creatorcontrib>Jwair, Noor A ; Al-Ouqaili, Mushtak T S ; Al-Marzooq, Farah</creatorcontrib><description>Antimicrobial resistance, with the production of extended-spectrum β-lactamases (ESBL) and carbapenemases, is common in the opportunistic pathogen,
. This organism has a genome that can contain clustered regularly interspaced short palindromic repeats (CRISPRs), which operate as a defense mechanism against external invaders such as plasmids and viruses. This study aims to determine the association of the CRISPR/Cas systems with antibiotic resistance in
isolates from Iraqi patients. A total of 100
isolates were collected and characterized according to their susceptibility to different antimicrobial agents. The CRISPR/Cas systems were detected via PCR. The phenotypic detection of ESBLs and carbapenemases was performed. The production of ESBL was detected in 71% of the isolates. Carbapenem-resistance was detected in 15% of the isolates, while only 14% were susceptible to all antimicrobial agents. Furthermore, the bacteria were classified into multidrug (77%), extensively drug-resistant (11.0%) and pandrug-resistant (4.0%). There was an inverse association between the presence of the CRISPR/Cas systems and antibiotic resistance, as resistance was higher in the absence of the CRISPR/Cas system. Multidrug resistance in ESBL-producing and carbapenem-resistant
occurred more frequently in strains negative for the CRISPR/Cas system. Thus, we conclude that genes for exogenous antibiotic resistance can be acquired in the absence of the CRISPR/Cas modules that can protect the bacteria against acquiring foreign DNA.</description><identifier>ISSN: 2079-6382</identifier><identifier>EISSN: 2079-6382</identifier><identifier>DOI: 10.3390/antibiotics12060980</identifier><identifier>PMID: 37370299</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Antibiotic resistance ; Antibiotics ; Antimicrobial agents ; Antimicrobial resistance ; Bacteria ; Carbapenemase ; carbapenemases ; CRISPR ; CRISPR/Cas ; Deoxyribonucleic acid ; DNA ; Drug resistance ; Enzymes ; extended-spectrum β-lactamases ; Genomes ; Genotype & phenotype ; Infections ; K. pneumoniae ; Klebsiella ; Klebsiella pneumoniae ; Multidrug resistance ; Opportunist infection ; Plasmids ; Viruses ; β Lactamase</subject><ispartof>Antibiotics (Basel), 2023-05, Vol.12 (6), p.980</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-d07803ae2853bbfc2942e7de01714c1f3885e0b664ddcd510b3603a660f475a03</citedby><cites>FETCH-LOGICAL-c500t-d07803ae2853bbfc2942e7de01714c1f3885e0b664ddcd510b3603a660f475a03</cites><orcidid>0000-0001-5711-6264</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2829697877/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2829697877?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37370299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jwair, Noor A</creatorcontrib><creatorcontrib>Al-Ouqaili, Mushtak T S</creatorcontrib><creatorcontrib>Al-Marzooq, Farah</creatorcontrib><title>Inverse Association between the Existence of CRISPR/Cas Systems with Antibiotic Resistance, Extended Spectrum β-Lactamase and Carbapenemase Production in Multidrug, Extensive Drug and Pandrug-Resistant Klebsiella pneumoniae</title><title>Antibiotics (Basel)</title><addtitle>Antibiotics (Basel)</addtitle><description>Antimicrobial resistance, with the production of extended-spectrum β-lactamases (ESBL) and carbapenemases, is common in the opportunistic pathogen,
. This organism has a genome that can contain clustered regularly interspaced short palindromic repeats (CRISPRs), which operate as a defense mechanism against external invaders such as plasmids and viruses. This study aims to determine the association of the CRISPR/Cas systems with antibiotic resistance in
isolates from Iraqi patients. A total of 100
isolates were collected and characterized according to their susceptibility to different antimicrobial agents. The CRISPR/Cas systems were detected via PCR. The phenotypic detection of ESBLs and carbapenemases was performed. The production of ESBL was detected in 71% of the isolates. Carbapenem-resistance was detected in 15% of the isolates, while only 14% were susceptible to all antimicrobial agents. Furthermore, the bacteria were classified into multidrug (77%), extensively drug-resistant (11.0%) and pandrug-resistant (4.0%). There was an inverse association between the presence of the CRISPR/Cas systems and antibiotic resistance, as resistance was higher in the absence of the CRISPR/Cas system. Multidrug resistance in ESBL-producing and carbapenem-resistant
occurred more frequently in strains negative for the CRISPR/Cas system. Thus, we conclude that genes for exogenous antibiotic resistance can be acquired in the absence of the CRISPR/Cas modules that can protect the bacteria against acquiring foreign DNA.</description><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial resistance</subject><subject>Bacteria</subject><subject>Carbapenemase</subject><subject>carbapenemases</subject><subject>CRISPR</subject><subject>CRISPR/Cas</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Drug resistance</subject><subject>Enzymes</subject><subject>extended-spectrum β-lactamases</subject><subject>Genomes</subject><subject>Genotype & phenotype</subject><subject>Infections</subject><subject>K. pneumoniae</subject><subject>Klebsiella</subject><subject>Klebsiella pneumoniae</subject><subject>Multidrug resistance</subject><subject>Opportunist infection</subject><subject>Plasmids</subject><subject>Viruses</subject><subject>β Lactamase</subject><issn>2079-6382</issn><issn>2079-6382</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUttuEzEQXSEQrUq_AAlZ4oUHltrrvfkJRaFARBBRAs8rX2YTR7t2antT-lt8CN_Ap-BcGrUIP9gz43POjMeTJC8Jfkcpw1fcBC20DVp6kuESsxo_Sc4zXLG0pHX29IF9llx6v8ZxMUJrXD9PzmhFK5wxdp78mZgtOA9o5L2VmgdtDRIQbgEMCitA1z-1D2AkINui8XyymM2vxtyjxV0M9x7d6rBCo1M1aA4-EngkvI3cyFSg0GIDMrihR79_pVMuA-95TMmNQmPuBN-AgX1k5qwa5L4GbdDXoQtauWF5VPJ6C-hD9PfMWdyind4nDOhLB8Jr6DqONgaG3hrN4UXyrOWdh8vjeZH8-Hj9ffw5nX77NBmPpqksMA6pwlWNKYesLqgQrcxYnkGlAJOK5JK0tK4LwKIsc6WkKggWtIz4ssRtXhUc04tkctBVlq-bjdM9d3eN5brZB6xbNtzFBnXQYAK8ICDyVvG8oJyJoigFIQWvW1HRndb7g9ZmED0oCSY43j0SfXxj9KpZ2m1D4qcWGSFR4c1RwdmbAXxoeu3lrjUG7OCbrKa4LBmrWIS-_ge6toMzsVcRlbGSVXVVRRQ9oKSz3jtoT9UQ3OwmsvnPREbWq4cPOXHu54_-BXwE5VI</recordid><startdate>20230529</startdate><enddate>20230529</enddate><creator>Jwair, Noor A</creator><creator>Al-Ouqaili, Mushtak T S</creator><creator>Al-Marzooq, Farah</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5711-6264</orcidid></search><sort><creationdate>20230529</creationdate><title>Inverse Association between the Existence of CRISPR/Cas Systems with Antibiotic Resistance, Extended Spectrum β-Lactamase and Carbapenemase Production in Multidrug, Extensive Drug and Pandrug-Resistant Klebsiella pneumoniae</title><author>Jwair, Noor A ; Al-Ouqaili, Mushtak T S ; Al-Marzooq, Farah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-d07803ae2853bbfc2942e7de01714c1f3885e0b664ddcd510b3603a660f475a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial resistance</topic><topic>Bacteria</topic><topic>Carbapenemase</topic><topic>carbapenemases</topic><topic>CRISPR</topic><topic>CRISPR/Cas</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Drug resistance</topic><topic>Enzymes</topic><topic>extended-spectrum β-lactamases</topic><topic>Genomes</topic><topic>Genotype & phenotype</topic><topic>Infections</topic><topic>K. pneumoniae</topic><topic>Klebsiella</topic><topic>Klebsiella pneumoniae</topic><topic>Multidrug resistance</topic><topic>Opportunist infection</topic><topic>Plasmids</topic><topic>Viruses</topic><topic>β Lactamase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jwair, Noor A</creatorcontrib><creatorcontrib>Al-Ouqaili, Mushtak T S</creatorcontrib><creatorcontrib>Al-Marzooq, Farah</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Antibiotics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jwair, Noor A</au><au>Al-Ouqaili, Mushtak T S</au><au>Al-Marzooq, Farah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inverse Association between the Existence of CRISPR/Cas Systems with Antibiotic Resistance, Extended Spectrum β-Lactamase and Carbapenemase Production in Multidrug, Extensive Drug and Pandrug-Resistant Klebsiella pneumoniae</atitle><jtitle>Antibiotics (Basel)</jtitle><addtitle>Antibiotics (Basel)</addtitle><date>2023-05-29</date><risdate>2023</risdate><volume>12</volume><issue>6</issue><spage>980</spage><pages>980-</pages><issn>2079-6382</issn><eissn>2079-6382</eissn><abstract>Antimicrobial resistance, with the production of extended-spectrum β-lactamases (ESBL) and carbapenemases, is common in the opportunistic pathogen,
. This organism has a genome that can contain clustered regularly interspaced short palindromic repeats (CRISPRs), which operate as a defense mechanism against external invaders such as plasmids and viruses. This study aims to determine the association of the CRISPR/Cas systems with antibiotic resistance in
isolates from Iraqi patients. A total of 100
isolates were collected and characterized according to their susceptibility to different antimicrobial agents. The CRISPR/Cas systems were detected via PCR. The phenotypic detection of ESBLs and carbapenemases was performed. The production of ESBL was detected in 71% of the isolates. Carbapenem-resistance was detected in 15% of the isolates, while only 14% were susceptible to all antimicrobial agents. Furthermore, the bacteria were classified into multidrug (77%), extensively drug-resistant (11.0%) and pandrug-resistant (4.0%). There was an inverse association between the presence of the CRISPR/Cas systems and antibiotic resistance, as resistance was higher in the absence of the CRISPR/Cas system. Multidrug resistance in ESBL-producing and carbapenem-resistant
occurred more frequently in strains negative for the CRISPR/Cas system. Thus, we conclude that genes for exogenous antibiotic resistance can be acquired in the absence of the CRISPR/Cas modules that can protect the bacteria against acquiring foreign DNA.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>37370299</pmid><doi>10.3390/antibiotics12060980</doi><orcidid>https://orcid.org/0000-0001-5711-6264</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2079-6382 |
ispartof | Antibiotics (Basel), 2023-05, Vol.12 (6), p.980 |
issn | 2079-6382 2079-6382 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_01ea51eb4fda453a9b556b115a8fb730 |
source | Publicly Available Content Database; PubMed Central |
subjects | Antibiotic resistance Antibiotics Antimicrobial agents Antimicrobial resistance Bacteria Carbapenemase carbapenemases CRISPR CRISPR/Cas Deoxyribonucleic acid DNA Drug resistance Enzymes extended-spectrum β-lactamases Genomes Genotype & phenotype Infections K. pneumoniae Klebsiella Klebsiella pneumoniae Multidrug resistance Opportunist infection Plasmids Viruses β Lactamase |
title | Inverse Association between the Existence of CRISPR/Cas Systems with Antibiotic Resistance, Extended Spectrum β-Lactamase and Carbapenemase Production in Multidrug, Extensive Drug and Pandrug-Resistant Klebsiella pneumoniae |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T01%3A00%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inverse%20Association%20between%20the%20Existence%20of%20CRISPR/Cas%20Systems%20with%20Antibiotic%20Resistance,%20Extended%20Spectrum%20%CE%B2-Lactamase%20and%20Carbapenemase%20Production%20in%20Multidrug,%20Extensive%20Drug%20and%20Pandrug-Resistant%20Klebsiella%20pneumoniae&rft.jtitle=Antibiotics%20(Basel)&rft.au=Jwair,%20Noor%20A&rft.date=2023-05-29&rft.volume=12&rft.issue=6&rft.spage=980&rft.pages=980-&rft.issn=2079-6382&rft.eissn=2079-6382&rft_id=info:doi/10.3390/antibiotics12060980&rft_dat=%3Cproquest_doaj_%3E2829697877%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c500t-d07803ae2853bbfc2942e7de01714c1f3885e0b664ddcd510b3603a660f475a03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2829697877&rft_id=info:pmid/37370299&rfr_iscdi=true |